3.20
price down icon0.31%   -0.010
pre-market  시장 영업 전:  3.24   0.04   +1.25%
loading
전일 마감가:
$3.21
열려 있는:
$3.16
하루 거래량:
4.19M
Relative Volume:
0.48
시가총액:
$953.51M
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-8.2051
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
-3.32%
1개월 성능:
-15.57%
6개월 성능:
+128.57%
1년 성능:
+254.37%
1일 변동 폭
Value
$3.11
$3.29
1주일 범위
Value
$2.99
$3.425
52주 변동 폭
Value
$0.6513
$5.225

Precigen Inc Stock (PGEN) Company Profile

Name
명칭
Precigen Inc
Name
전화
301-556-9900
Name
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
직원
25
Name
트위터
@precigen
Name
다음 수익 날짜
2025-03-19
Name
최신 SEC 제출 서류
Name
PGEN's Discussions on Twitter

PGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PGEN
Precigen Inc
3.20 1.10B 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Precigen Inc Stock (PGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-15 업그레이드 JP Morgan Underweight → Neutral
2024-03-22 다운그레이드 JP Morgan Neutral → Underweight
2023-05-23 개시 JP Morgan Neutral
2022-11-18 개시 Cantor Fitzgerald Overweight
2021-02-25 개시 Stifel Buy
2021-02-22 개시 Wells Fargo Overweight
2021-02-18 개시 B. Riley Securities Buy
2020-05-08 개시 H.C. Wainwright Buy
모두보기

Precigen Inc 주식(PGEN)의 최신 뉴스

pulisher
Oct 14, 2025

Why Precigen Inc. stock appeals to dividend seekersEarnings Trend Report & Weekly Return Optimization Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How Precigen Inc. stock performs in high volatility marketsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will a bounce in Precigen Inc. offer an exitGap Up & Fast Entry Momentum Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Institutional scanner results for Precigen Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to integrate Precigen Inc. into portfolio analysis toolsTrade Performance Summary & Consistent Income Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Precigen Says Drug for Rare Respiratory Disease Shows Durable Outcomes - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

Precigen reports durable responses to RRP treatment in long-term data - Investing.com Nigeria

Oct 13, 2025
pulisher
Oct 13, 2025

Precigen (PGEN) Showcases Promising Results for PAPZIMEOS in Tre - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis - Yahoo Finance

Oct 13, 2025
pulisher
Oct 10, 2025

Using flow based indicators on Precigen Inc.Market Volume Summary & Free Technical Pattern Based Buy Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Analyzing recovery setups for Precigen Inc. investorsWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Precigen (NASDAQ:PGEN) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

How to monitor Precigen Inc. with trend dashboardsJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem With 158% Upside Potential - DirectorsTalk Interviews

Oct 10, 2025
pulisher
Oct 09, 2025

Will Precigen Inc. stock deliver long term returns2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why Precigen Inc. stock is seen as undervaluedJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Precigen Inc. stock deliver consistent dividendsMarket Trend Review & Low Drawdown Trading Techniques - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Precigen (NASDAQ:PGEN) Trading 5.6% HigherStill a Buy? - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Chart based analysis of Precigen Inc. trends2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Precigen Inc. stock ready for a breakoutJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Volatility clustering patterns for Precigen Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World

Oct 04, 2025
pulisher
Oct 03, 2025

Have Precigen Insiders Been Selling Stock? - 富途牛牛

Oct 03, 2025
pulisher
Oct 03, 2025

Precigen, Inc. (PGEN) Stock Analysis: A 147.75% Upside Beckons Biotech Investors - DirectorsTalk Interviews

Oct 03, 2025
pulisher
Oct 03, 2025

What machine learning models say about Precigen Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN

Oct 01, 2025
pulisher
Oct 01, 2025

Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

Precigen (NASDAQ:PGEN) Director Sells $243,082.80 in Stock - MarketBeat

Oct 01, 2025
pulisher
Oct 01, 2025

Jeffrey Kindler Sells 106,837 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat

Oct 01, 2025
pulisher
Oct 01, 2025

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - MSN

Oct 01, 2025
pulisher
Sep 30, 2025

Insider Buying: Phil Tennant Acquires Shares of Precigen Inc (PG - GuruFocus

Sep 30, 2025
pulisher
Sep 30, 2025

Precigen (NASDAQ:PGEN) Director Randal Kirk Sells 1,809,667 Shares - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

Cantor Fitzgerald Forecasts Weaker Earnings for Precigen - MarketBeat

Sep 29, 2025
pulisher
Sep 28, 2025

Is Precigen Inc a good long term investmentEarnings Growth Projections & Free Realize Exceptional Returns - earlytimes.in

Sep 28, 2025

Precigen Inc (PGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Precigen Inc 주식 (PGEN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
KINDLER JEFFREY B
Director
Sep 29 '25
Sale
3.60
67,523
243,083
452,907
KIRK RANDAL J
Director
Sep 30 '25
Sale
3.41
1,809,667
6,170,964
14,597,161
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
자본화:     |  볼륨(24시간):